|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.110 USD | +4.31% |
|
+1.48% | -43.00% |
| 11-06 | Altimmune Inc files for mixed shelf of up to $400 million - SEC filing | RE |
| 11-06 | Altimmune files for offering of common stock of up to $200 million - filing | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- ALT Stock
- Consensus Altimmune, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition